Services

May 3, 2023

Partnering for CMC Writing in New Drug Application

CMC writing is a standardized scientific and technical writing process
May 1, 2023

Risk Evaluation & Mitigation Strategies: Needs, Challenges and Solutions

March 6, 2023

Establishing a regulatory roadmap for post-approval lifecycle management

A drug product transitions from different phases throughout its life
September 30, 2022

Managing Seamless Transition and Establishing KPI driven Operations

Managing Medical information (MI) services in-house is a major challenge
September 2, 2022

Updating a complex Investigator Brochure (IB) for an oncology product within demanding timelines

Our Medical Writing team helped the client in updating and
August 8, 2022
pharmacovigilance service providers in uk

Designing a Safety and Risk Management System for Cellular Therapies

May 18, 2022

Standardization and publication of evidence-based local recommendations for pharmacological treatment of pain

We supported a large biopharma company in preparing manuscript/narrative review
April 21, 2022
pharmacovigilance services

Scaling up to address safety challenges for an Oncology product

APCER life sciences through its oncology expertise helped the pharma
December 8, 2021

Role of CAR-T therapies in haematological malignancies

April 5, 2021

Regulatory considerations for cellular and gene therapy products in EU and US: A comparative analysis

March 9, 2021

Classification of cellular therapy and gene therapy (CGT) products: How regulators are working with industry

March 9, 2021

A Quick Guide to Referencing an Approved Product for ANDA

March 8, 2021
pharmacovigilance consulting services

End-to-end pharmacovigilance support for a UK-based pharmaceutical company

APCER’s Pharmacovigilance (PV) team supported a client’s expansion into new
March 8, 2021

Setting up Agile PV operations for a US based Pharma company

APCER’s Pharmacovigilance (PV) team helped a biotech pharmaceutical company with
March 8, 2021

Final Guidance on Competitive Generics Therapy (CGT): Opportunity to benefit from 180-day market exclusivity

March 8, 2021

Enabling compliance through strong PSMF management & QPPV oversight

APCER helped a leading generics company to streamline its PV
March 8, 2021

Established a unified, global PV system for a pharma company after multiple M&A

We helped a large pharmaceutical company successfully transition its pharmacovigilance
March 8, 2021

Accelerating product approval by handling complex and voluminous medical writing projects

Our Medical Writing team helped the client in handling e-submission
March 8, 2021
end to end pharmacovigilance

Enabling global expansion by establishing an integrated PV system

APCER helped a global pharmaceutical company in establishing a collaborative
March 8, 2021

Active remediation measures help mitigate major safety findings

APCER Life Sciences supported one of the biopharma companies in
March 8, 2021

Efficient Risk Management Support for Marketing Authorization Applications in LATAM Region for a Leading Pharma Company

APCER Life Sciences supported a leading generic pharma company with
March 8, 2021

Efficiently navigating the regulatory submission landscape

The Regulatory Affairs team at APCER Life sciences helped the
March 8, 2021

Inspection Readiness: Supporting the pharma company in ensuring regulatory compliance with highest standards

Read how our Quality Assurance team helped a pharma company
March 8, 2021

Streamlining lifecycle management through proficient eCTD submission roadmap

APCER’s Pharmacovigilance (PV) team provided PV services right from set
March 8, 2021

GCP Audits in EU requiring local language competency for a biopharma company

We helped a biopharma company to set up end-to-end Quality
March 8, 2021

Significance of Medical Monitoring in smooth progression of clinical trials

APCER Life Sciences helped develop the strategy and provided medical
March 8, 2021

Bridging the gaps and inconsistencies within CT program through an expert overlay of medical monitors

Our medical monitoring team with experience and expertise in early
January 13, 2021

Future Business Outlook

Mr. Tejus Menon, Executive Director shares his perspective on what
January 12, 2021

Importance of Engaging a Safety Partner Early in the Drug Life Cycle

Ms. Jeanne Schow, Vice President & US Head of Business
January 10, 2021

Risk minimisation measures: Tracking and effectiveness assessment

January 10, 2021

Quality Assurance services

Our team of experienced auditors help the bio-pharma companies achieve
January 10, 2021

Medical Writing Services

Our team of efficient and experienced medical writers support the
January 10, 2021

The Need for Vigilance

APCER Life Sciences provides the expertise and support required for
January 8, 2021

Pharmaceutical Product Lifecycle Management: A Regulatory Consideration

January 6, 2021

RMP Team Collaboration Across Functions

January 6, 2021

aRMM Implementation Strategy

January 6, 2021

Identification of risks and determination of aRRM requirement

January 6, 2021

Medical Information Services

APCER Life Sciences provides 24×7 fully customizable, multi-channel and multi-lingual
January 6, 2021

Regulatory Affairs Services

We offer end-to-end regulatory consulting and execution support services to
January 6, 2021

APCER Factsheet

Snapshot of end-to-end Safety services offered by APCER Life Sciences.
December 11, 2020

Advanced Therapy Medicinal Products – The Next Therapeutic Revolution

Dr. Vineet Kacker, Managing Director & Global Technical Head talks
December 11, 2020

Business Continuity – An Agile Approach

November 5, 2020

Human medicinal products containing nitrosamine impurities: Regulatory landscape in the United States and the European Union

September 11, 2020

Personalized Therapy with Advanced Therapy Medicinal Products: A Paradigm Shift